Michael L Gagnon

Title: Michael L Gagnon: Innovator in Vascular Research

Introduction

Michael L Gagnon is a notable inventor based in Brighton, MA (US). He has made significant contributions to the field of vascular research, particularly through his innovative patents. With a total of 3 patents, Gagnon has established himself as a key figure in medical advancements.

Latest Patents

One of Gagnon's latest patents is focused on soluble inhibitors of vascular endothelial growth factor. This invention relates to cDNA encoding a soluble neuropilin protein (sNP) that is isolated from neuropilin (NP) producing cells or is recombinantly engineered from NP-encoding DNA. The patent emphasizes the importance of NP-1 and NP-2 as preferred neuropilins, while also allowing for any neuropilin or VEGF receptor (VEGFR) that shares at least about 85% homology with either of the above. More specifically, the invention highlights constituents that share at least 90% and even 95% homology.

Career Highlights

Gagnon is currently associated with the Children's Medical Center Corporation, where he continues to work on groundbreaking research. His career is marked by a commitment to advancing medical science and improving patient outcomes through innovative solutions.

Collaborations

Throughout his career, Gagnon has collaborated with esteemed colleagues, including Michael Klagsbrun and Shay Soker. These partnerships have further enriched his research and contributed to the success of his inventions.

Conclusion

Michael L Gagnon is a distinguished inventor whose work in vascular research has led to significant advancements in medical science. His innovative patents and collaborations reflect his dedication to improving healthcare through research and development.